X-153743540-C-T

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_000033.4(ABCD1):​c.2043C>T​(p.Phe681Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000306 in 1,201,573 control chromosomes in the GnomAD database, including 1 homozygotes. There are 128 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00026 ( 0 hom., 11 hem., cov: 24)
Exomes 𝑓: 0.00031 ( 1 hom. 117 hem. )

Consequence

ABCD1
NM_000033.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.27

Publications

0 publications found
Variant links:
Genes affected
ABCD1 (HGNC:61): (ATP binding cassette subfamily D member 1) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ALD subfamily, which is involved in peroxisomal import of fatty acids and/or fatty acyl-CoAs in the organelle. All known peroxisomal ABC transporters are half transporters which require a partner half transporter molecule to form a functional homodimeric or heterodimeric transporter. This peroxisomal membrane protein is likely involved in the peroxisomal transport or catabolism of very long chain fatty acids. Defects in this gene have been identified as the underlying cause of adrenoleukodystrophy, an X-chromosome recessively inherited demyelinating disorder of the nervous system. [provided by RefSeq, Jul 2008]
PLXNB3-AS1 (HGNC:40454): (PLXNB3 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant X-153743540-C-T is Benign according to our data. Variant chrX-153743540-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 528352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.27 with no splicing effect.
BS2
High AC in GnomAd4 at 29 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCD1NM_000033.4 linkc.2043C>T p.Phe681Phe synonymous_variant Exon 10 of 10 ENST00000218104.6 NP_000024.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCD1ENST00000218104.6 linkc.2043C>T p.Phe681Phe synonymous_variant Exon 10 of 10 1 NM_000033.4 ENSP00000218104.3
PLXNB3-AS1ENST00000434284.1 linkn.72-4962G>A intron_variant Intron 1 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.000257
AC:
29
AN:
112687
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.0000322
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000356
Gnomad FIN
AF:
0.000160
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000489
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000360
AC:
59
AN:
163919
AF XY:
0.000428
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000423
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000338
Gnomad NFE exome
AF:
0.000648
Gnomad OTH exome
AF:
0.000243
GnomAD4 exome
AF:
0.000311
AC:
339
AN:
1088886
Hom.:
1
Cov.:
37
AF XY:
0.000328
AC XY:
117
AN XY:
356638
show subpopulations
African (AFR)
AF:
0.0000381
AC:
1
AN:
26247
American (AMR)
AF:
0.00
AC:
0
AN:
34455
Ashkenazi Jewish (ASJ)
AF:
0.000521
AC:
10
AN:
19206
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29929
South Asian (SAS)
AF:
0.000303
AC:
16
AN:
52810
European-Finnish (FIN)
AF:
0.000352
AC:
14
AN:
39720
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2881
European-Non Finnish (NFE)
AF:
0.000333
AC:
279
AN:
837963
Other (OTH)
AF:
0.000416
AC:
19
AN:
45675
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
15
29
44
58
73
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000257
AC:
29
AN:
112687
Hom.:
0
Cov.:
24
AF XY:
0.000316
AC XY:
11
AN XY:
34861
show subpopulations
African (AFR)
AF:
0.0000322
AC:
1
AN:
31069
American (AMR)
AF:
0.00
AC:
0
AN:
10737
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2654
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3558
South Asian (SAS)
AF:
0.000356
AC:
1
AN:
2807
European-Finnish (FIN)
AF:
0.000160
AC:
1
AN:
6243
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.000489
AC:
26
AN:
53193
Other (OTH)
AF:
0.00
AC:
0
AN:
1504
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000434
Hom.:
3
Bravo
AF:
0.000306

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Adrenoleukodystrophy Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jan 11, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 14, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Nov 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ABCD1: BP4, BP7, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
2.4
DANN
Benign
0.90
PhyloP100
-1.3
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782327280; hg19: chrX-153008994; API